Concepedia

Stacey Curelop

SC

Statistics

Publications

3

Citations

162

H-Index

3

Active since

2020

Affiliations

Mycovia Pharmaceuticals (United States)(Current)

Case Western Reserve University

Stacey Curelop is an author at Mycovia Pharmaceuticals (United States) specializing in pharmacology, antifungal therapy, and antifungal pharmacology.

ORCID

Publications per year

2020–2022

3

Publications

3

Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections

Mark G. Martens, Bassem Maximos, Thorsten P. Degenhardt et al. · American Journal of Obstetrics and Gynecology · 2022 · 77 citations · Full text

, , +16

Efficacy and Safety of Oteseconazole in Recurrent Vulvovaginal Candidiasis

Jack D. Sobel, Gilbert Donders, Thorsten P. Degenhardt et al. · NEJM Evidence · 2022 · 46 citations

, , +17

A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study to evaluate the efficacy and safety of VT‐1161 oral tablets in the treatment of patients with distal and lateral subungual onychomycosis of the toenail*

Boni E. Elewski, Stephen Brand, Thorsten P. Degenhardt et al. · British Journal of Dermatology · 2020 · 39 citations

, , +17

1–3 of 3